4.2 Editorial Material

Induced pluripotent stem cells (iPSCs) derived from a symptomatic carrier of a S305I mutation in the microtubule-associated protein tau (MAPT)-gene causing frontotemporal dementia

Journal

STEM CELL RESEARCH
Volume 17, Issue 3, Pages 564-567

Publisher

ELSEVIER
DOI: 10.1016/j.scr.2016.10.006

Keywords

-

Funding

  1. Danish Agency for Science, Technology and Innovation [6114-00003B-768138]
  2. People Programme (Marie Curie Actions) of the European Union's Seventh Framework programme FP7 under REA grant agreement (STEMMAD) [PIAPP-GA-2012-324451]
  3. Innovation Fund Denmark (BrainStem - Stem cell Centre of Excellence in Neurology) [4108-00008B]
  4. Novo Nordisk Fonden [NNF11OC1014514] Funding Source: researchfish

Ask authors/readers for more resources

Frontotemporal dementia with parkinsonism linked to chromosome 17q21.2 (FTDP-17) is an autosomal-dominant neurodegenerative disorder. Mutations in the gene coding the microtubule-associated protein tau (MAPT) can cause FTDP-17 but the underlying mechanisms of the disease are still unknown. Induced pluripotent stem cells (iPSCs) hold great promise to model FTDP-17 as such cells can be differentiated in vitro to the required neuronal cell type. Here, we report the generation of iPSCs from a 44-year-old symptomatic woman carrying a S305I mutation in the MAPT-gene. (C) 2016 The Authors. Published by Elsevier B.V.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available